Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Verner

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|November 2, 2001
Exploiting subsite S1 of trypsin-like serine proteases for selectivity: potent and selective inhibitors of urokinase-type plasminogen activatorR L Mackman, B A Katz, J G Breitenbucher, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Properties and purification of an active biotinylated lactose permease from Escherichia coliT G Consler, B L Persson, H Jung, et al.
Developmental Genetics|January 1, 1995
Transmission-ratio distortion of X chromosomes among male offspring of females with skewed X-inactivationA K Naumova, L Olien, L M Bird, et al.
Genetics|January 11, 2000
Sex-of-offspring-specific transmission ratio distortion on mouse chromosome XE de la Casa-Esperon, F Pardo-Manuel de Villena, A E Verner, et al.
Chemistry & Biology|December 4, 2001
Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targetsB A Katz, P A Sprengeler, C Luong, et al.
Journal of Molecular Biology|April 9, 2001
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active siteB A Katz, K Elrod, C Luong, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Development of potent and selective factor Xa inhibitorsR Rai, A Kolesnikov, Y Li, et al.
Journal of Medicinal Chemistry|August 10, 2001
Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor XaE Verner, B A Katz, J R Spencer, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|November 2, 2001
Exploiting subsite S1 of trypsin-like serine proteases for selectivity: potent and selective inhibitors of urokinase-type plasminogen activatorR L Mackman, B A Katz, J G Breitenbucher, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Properties and purification of an active biotinylated lactose permease from Escherichia coliT G Consler, B L Persson, H Jung, et al.
Developmental Genetics|January 1, 1995
Transmission-ratio distortion of X chromosomes among male offspring of females with skewed X-inactivationA K Naumova, L Olien, L M Bird, et al.
Genetics|January 11, 2000
Sex-of-offspring-specific transmission ratio distortion on mouse chromosome XE de la Casa-Esperon, F Pardo-Manuel de Villena, A E Verner, et al.
Chemistry & Biology|December 4, 2001
Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targetsB A Katz, P A Sprengeler, C Luong, et al.
Journal of Molecular Biology|April 9, 2001
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active siteB A Katz, K Elrod, C Luong, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Development of potent and selective factor Xa inhibitorsR Rai, A Kolesnikov, Y Li, et al.
Journal of Medicinal Chemistry|August 10, 2001
Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor XaE Verner, B A Katz, J R Spencer, et al.
Pageof 3